Panel Discussion: Lowering the Barrier to Entry for Oligonucleotide Drug Development
Time: 1:30 pm
day: Day Two PM
Details:
• How can companies in the oligo space collaborate to ease entry for small biotechs
• Exploring attempts to lower costs of analytical development and manufacturing and their subsequent impacts • Balancing innovation of analytical methods and technology versus cost- saving practises
